BamSEC and AlphaSense Join Forces
Learn More

Enzon Pharmaceuticals Inc

OTC: ENZN    
Share price (1/14/26): $0.04    
Market cap (1/14/26): $3.117 million
Search in Documents
Key Exhibits
External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

EX-2.1
from 425 10 pages First Amendment to the Agreement and Plan of Merger
12/34/56
EX-2.1
from 8-K 10 pages First Amendment to the Agreement and Plan of Merger
12/34/56
EX-2.1
from 8-K 102 pages Agreement and Plan of Merger by and Between Enzon Pharmaceuticals, Inc., Epsc Acquisition Corp., and Viskase Companies, Inc. Dated as of June 20, 2025
12/34/56
EX-2.1
from 425 102 pages Agreement and Plan of Merger by and Between Enzon Pharmaceuticals, Inc., Epsc Acquisition Corp., and Viskase Companies, Inc. Dated as of June 20, 2025
12/34/56
EX-2.1
from DEFA14A 4 pages Plan of Liquidation and Dissolution of Enzon Pharmaceuticals, Inc
12/34/56
EX-2.1
from 8-K 4 pages Plan of Liquidation and Dissolution of Enzon Pharmaceuticals, Inc
12/34/56
EX-2.1
from 8-K 96 pages Asset Purchase Agreement by and Between Klee Pharmaceuticals, Inc., Defiante Farmacêutica, S.A. and Sigma-Tau Finanziaria S.P.A., (Solely for the Purpose of Section 6.4, Section 7.8(a), Section 7.8(e) and Section 12.17), on the One Hand, and Enzon Pharmaceuticals, Inc., on the Other Hand Dated as of November 9, 2009
12/34/56
EX-2.1
from 8-K >50 pages Agreement and Plan of Reorgnization
12/34/56
EX-2
from 8-A12G/A ~5 pages First Amendment to Rights Agreement
12/34/56
EX-2.1
from SC 13G/A 1 page Statement of Control Person
12/34/56
EX-2.1
from SC 13G/A 1 page Statement of Control Person
12/34/56
EX-2.1
from SC 13G/A 1 page Statement of Control Person
12/34/56
EX-2
from 8-K >50 pages Exhibit 2.1 Asset Purchase Agreement
12/34/56
EX-2.1
from SC 13G 1 page Statement of Control Person
12/34/56
EX-2.1
from SC 13G 1 page Statement of Control Person
12/34/56
EX-2.1
from SC 13G 1 page Statement of Control Person
12/34/56